Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2015

01-02-2015 | Breast Oncology

The Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Invasive Breast Cancer in the Post-ACOSOG Z0011 Trial Era

Authors: N. C. Verheuvel, MSc, MD, I. van den Hoven, MD, H. W. A. Ooms, MD, PhD, A. C. Voogd, PhD, R. M. H. Roumen, MD, PhD

Published in: Annals of Surgical Oncology | Issue 2/2015

Login to get access

Abstract

Background

Axillary status in invasive breast cancer, established by sentinel lymph node biopsy (SLNB) or ultrasound-guided lymph node biopsy, is an important prognostic indicator. The ACOSOG Z0011 trial showed that axillary dissection may be redundant in selected sentinel node-positive patients, raising questions on the applicability of these conclusions on ultrasound positive patients. The purpose of this study was to evaluate potential differences in patient and tumor characteristics and survival between axillary node positive patients after ultrasound (US group) or sentinel lymph node procedure (SN group).

Methods

Patients diagnosed with invasive breast cancer at the Máxima Medical Center between January 2006 and December 2011 were studied.

Results

In total, 302 node-positive cases were included: 139 and 163 cases in the US and SN groups, respectively. Patients in the US group were older at diagnosis (p < 0.001), more often had palpable nodes (p < 0.001), mastectomy (p < 0.001), larger tumors (p < 0.001), higher tumor grade (p = 0.001), lymphovascular invasion (p = 0.035), a positive Her2Neu (p = 0.006), and a negative hormonal receptor status (p = 0.003). Also, they were more likely to have more lymph nodes with macrometastases (p < 0.001), extranodal extension (p < 0.001), and involvement of level-III-lymph node (p < 0.001). Finally, they showed a worse disease-free survival [hazard ratio (HR) = 2.71; 95 % confidence interval (CI) = 1.49–4.92] and overall survival (HR = 2.67; 95 % CI = 1.48–4.84) than the SN group.

Conclusions

These results suggest that ultrasound-positive patients have less favorable disease characteristics and a worse prognosis than SN-positive patients. Therefore, we conclude that omitting an ALND is as yet only applicable, as concluded in the Z0011, in patients with a positive SLNB.
Literature
1.
Donker M, Straver ME, van Tienhoven G, et al. Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS trial: Identification rate and nodal outcome. Eur J Cancer. 2013;49(9):2093–2100.PubMedCrossRef
2.
Parra RF, Ernst MF, Bevilacqua JL, et al. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: Validation of the MSKCC breast nomogram. Ann Surg Oncol. 2009;16(5):1128-35.CrossRef
3.
4.
Senkus E, Kyriakides S, Penault-Llorca F, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi7-23.PubMedCrossRef
5.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines 2014); breast cancer version 1.2014. www.​nccn.​com. Accessed 5 Jan 2014.
6.
Rajesh YS, Ellenbogen S, Banerjee B. Preoperative axillary ultrasound scan: its accuracy in assessing the axillary nodal status in carcinoma breast. Breast. 2002;11(1):49-52.PubMedCrossRef
7.
Specht MC, Fey JV, Borgen PI, Cody HS 3rd. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg. 2005;200(1):10-4.PubMedCrossRef
8.
Gur AS, Unal B, Ozbek U, et al. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol. 2010;36(1):30-5.PubMedCrossRef
9.
Coufal O, Pavlik T, Fabian P, et al. Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a czech population? Pathol Oncol Res. 2009;15(4):733-40.PubMedCrossRef
10.
Coutant C, Rouzier R, Fondrinier E, et al. Validation of the tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Breast Cancer Res Treat. 2009;113(3):537-43.PubMedCrossRef
11.
Nath J, Sami N, Massey J, Donnelly J, Corder AP. Selection for axillary clearance in breast cancer (ultrasound negative, sentinel node positive patients have low rates of further metastases). Eur J Surg Oncol. 2013;39(5):450-4.PubMedCrossRef
12.
Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA. 2011;305(6):569-75.PubMedCrossRef
13.
Swinson C, Ravichandran D, Nayagam M, Allen S. Ultrasound and fine needle aspiration cytology of the axilla in the pre-operative identification of axillary nodal involvement in breast cancer. Eur J Surg Oncol. 2009;35(11):1152-7.PubMedCrossRef
14.
Hackney L, Williams S, Bajwa S, Morley-Davies AJ, Kirby RM, Britton I. Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla. Breast J. 2013;19(1):49-55.PubMedCrossRef
15.
Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol. 1999;25(4):347-51.PubMedCrossRef
16.
Roumen RM, Valkenburg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol. 1997;23(6):495-502.PubMedCrossRef
17.
Rao R, Euhus D, Mayo HG, Balch C. Axillary node interventions in breast cancer: A systematic review. JAMA. 2013;310(13):1385-94.PubMedCrossRef
18.
Katz A, Smith BL, Golshan M, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008;26(13):2093-8.PubMedCrossRef
19.
Van Wely BJ, de Wilt JH, Schout PJ, et al. Ultrasound-guided fine-needle aspiration of suspicious nodes in breast cancer patients; selecting patients with extensive nodal involvement. Breast Cancer Res Treat. 2013;140(1):113-8.PubMedCrossRef
20.
Cools-Lartigue J, Sinclair A, Trabulsi N, et al. Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: Predictors of accuracy and future implications. Ann Surg Oncol. 2013;20(3):819-27.PubMedCrossRef
21.
Diepstraten SC, Sever AR, Buckens CF, et al. Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2014;21(1):51-9.PubMedCrossRef
22.
Houssami N, Diepstraten SC, Cody HS 3rd, Turner RM, Sever AR. Clinical utility of ultrasound-needle biopsy for preoperative staging of the axilla in invasive breast cancer. Anticancer Res. 2014;34(3):1087-97.PubMed
23.
Pesce C, Morrow M. The need for lymph node dissection in nonmetastatic breast cancer. Annu Rev Med. 2013;64:119-29.PubMedCrossRef
24.
Unal B, Gur AS, Beriwal S, et al. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Int J Radiat Oncol Biol Phys. 2009;75(4):1035-40.PubMedCrossRef
25.
Van den Hoven I, Kuijt GP, Voogd AC, Roumen RM. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer. Ann Surg Oncol. 2012;19(6):1841-9.PubMedCrossRef
26.
Van den Hoven I, Kuijt GP, Voogd AC, van Beek MW, Roumen RM. Value of memorial sloan-kettering cancer center nomogram in clinical decision making for sentinel lymph node-positive breast cancer. Br J Surg. 2010;97(11):1653-8.PubMedCrossRef
27.
Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):1140-51.PubMedCrossRef
28.
Cripe MH, Beran LC, Liang WC, Sickle-Santanello BJ. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: Validation of a nomogram. Am J Surg. 2006;192(4):484-7.PubMedCrossRef
29.
Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR Am J Roentgenol. 2013;200(3):696-702.PubMedCrossRef
30.
Rutgers EJT, Donker M, Straver ME, et. al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: final analysis of the EORTC AMAROS trial. J Clin Oncol. 2013;31(Suppl):abstr LBA1001.
Metadata
Title
The Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Invasive Breast Cancer in the Post-ACOSOG Z0011 Trial Era
Authors
N. C. Verheuvel, MSc, MD
I. van den Hoven, MD
H. W. A. Ooms, MD, PhD
A. C. Voogd, PhD
R. M. H. Roumen, MD, PhD
Publication date
01-02-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 2/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4071-1

Other articles of this Issue 2/2015

Annals of Surgical Oncology 2/2015 Go to the issue

Head and Neck Oncology

Cytoplasmic iASPP Expression as a Novel Prognostic Indicator in Oral Cavity Squamous Cell Carcinoma

Thoracic Oncology

Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients

Hepatobiliary Tumors

Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up

Gastrointestinal Oncology

Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative

Breast Oncology

Surgical Decision Making for Breast Cancer: Hitting the Sweet Spot Between Paternalism and Consumerism

Endocrine Tumors

All Cervical Sonography Is Not Created Equal